LAG-3 antagonists by cancer treatment: a patent review

Perez-Santos, M; Anaya-Ruiz, M; Cebada, J; Bandala, C; Landeta, G; Martinez-Morales, P; Villa-Ruano, N

Perez-Santos, M (reprint author), Benemerita Univ Autonoma Puebla, Ctr Univ Vinculac & Transferencia Tecnol, Av San Claudio S-N,Ciudad Univ, Puebla 72570, Mexico.

EXPERT OPINION ON THERAPEUTIC PATENTS, 2019; 29 (8): 643

Abstract

Introduction: LAG-3 is checkpoint inhibitor in cancer that coordinates the downregulation of the proliferation of antigen-specific lymphocytes. There ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索